Juan Ramón Alaix served as the CEO of Zoetis Inc. from 2012 to 2019, leading the company to become a global leader in animal health with around $6 billion in revenue. His background includes significant roles at Pfizer Animal Health,...

Juan Ramón Alaix served as the CEO of Zoetis Inc. from 2012 to 2019, leading the company to become a global leader in animal health with around $6 billion in revenue. His background includes significant roles at Pfizer Animal Health, where he was President prior to Zoetis. During his time as CEO, Zoetis saw impressive growth and introduced new groundbreaking products in the animal health market. His approach to compensation was performance-focused, earning over $21 million in 2019 primarily from his salary and bonuses, but interestingly, there were years without vested stock, showing an emphasis on long-term growth rather than immediate rewards. After stepping down in 2019, he continued to support Zoetis through a consulting role until 2020, receiving about $1.7 million for this transitional assistance. His departure from the company was smooth and not due to any disagreement, indicating a healthy leadership transition. Alaix holds a degree in Veterinary Medicine from the University of León in Spain and an MBA from the University of Michigan. His career reflects substantial experience in the pharmaceutical industry, specifically in animal health, shaping how Zoetis functions today.